FFA
ZYME icon

Farther Finance Advisors’s Zymeworks ZYME Stock Holding History

Farther Finance Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38K Buy
52
+22
+73% +$570 ﹤0.01% 5496
2026
Q2 		$784 Sell
30
-27
-47% -$686 ﹤0.01% 5429
2026
Q1 		$1.48K Sell
57
-222
-80% -$5.25K ﹤0.01% 4999
2025
Q4 		$7.35K Buy
279
+217
+350% +$4.73K ﹤0.01% 4106
2025
Q3 		$1.06K Buy
62
+37
+148% +$530 ﹤0.01% 4349
2025
Q2 		$314 Sell
25
-114
-82% -$1.36K ﹤0.01% 4130
2025
Q1 		$1.61K Sell
139
-11
-7% -$150 ﹤0.01% 3462
2024
Q4 		$2.2K Hold
150
– – ﹤0.01% 2963
2024
Q3 		$1.88K Hold
150
– – ﹤0.01% 3017
2024
Q2 		$1.29K Buy
150
+125
+500% +$1.11K ﹤0.01% 2972
2024
Q1 		$247 Hold
25
– – ﹤0.01% 3221
2023
Q4 		$260 Buy
+25
New +$199 ﹤0.01% 3166

Other funds holding ZYME

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's ZYME Position: Q3 2026 in Review

Farther Finance Advisors increased its Zymeworks (ZYME) stake by 73% in Q3 2026, buying an estimated $570 and bringing the position to 52 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5496.

Farther Finance Advisors first reported a position in ZYME in Q4 2023 and has held it in 12 quarters since. The position peaked at $7.35K in Q4 2025. 3 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Farther Finance Advisors held 52 shares of Zymeworks worth $1.38K as of Q3 2026.
  • Farther Finance Advisors bought 22 Zymeworks shares in Q3 2026, an estimated $570.
  • Zymeworks made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5496 holding.
  • Farther Finance Advisors first reported a position in Zymeworks in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Zymeworks position peaked at $7.35K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.